GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovix Corp (NAS:ENVX) » Definitions » Total Liabilities

Enovix (Enovix) Total Liabilities : $303.20 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Enovix Total Liabilities?

Enovix's Total Liabilities for the quarter that ended in Dec. 2023 was $303.20 Mil.

Enovix's quarterly Total Liabilities declined from Jun. 2023 ($291.67 Mil) to Sep. 2023 ($267.47 Mil) but then increased from Sep. 2023 ($267.47 Mil) to Dec. 2023 ($303.20 Mil).

Enovix's annual Total Liabilities declined from Dec. 2021 ($156.45 Mil) to Dec. 2022 ($84.16 Mil) but then increased from Dec. 2022 ($84.16 Mil) to Dec. 2023 ($303.20 Mil).


Enovix Total Liabilities Historical Data

The historical data trend for Enovix's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovix Total Liabilities Chart

Enovix Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Liabilities
28.75 156.45 84.16 303.20

Enovix Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 84.16 98.49 291.67 267.47 303.20

Enovix Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Enovix's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=61.018+(184.693+42.913
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+14.577+0)
=303.20

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=564.304-261.103
=303.20

Enovix's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=61.018+(184.693+42.913
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+14.577+0)
=303.20

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=564.304-261.103
=303.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enovix Total Liabilities Related Terms

Thank you for viewing the detailed overview of Enovix's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Enovix (Enovix) Business Description

Traded in Other Exchanges
Address
3501 W. Warren Avenue, Fremont, CA, USA, 94538
Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.
Executives
Rajendra K Talluri director, officer: President and CEO 3501 W. WARREN AVENUE, FREMONT CA 94538
Betsy S Atkins director
Arthi Chakravarthy officer: See Remarks C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Farhan Ahmad officer: Chief Financial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Bernard Gutmann director ON SEMICONDUCTOR C/O V PECORA (M/D A700), 5005 EAST MCDOWELL ROAD, PHOENIX AZ 85008
Ralph H Schmitt officer: Chief Commercial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Thurman J Rodgers director, 10 percent owner 535 EASTVIEW WAY, WOODSIDE CA 94062
Ashok Lahiri officer: Chief Technology Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Ajay Marathe officer: Chief Operating Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Harrold J Rust director, officer: President and CEO C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Gardner Cameron Dales officer: Chief Commercial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Eclipse Fund Iii, L.p. 10 percent owner 514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Eclipse Gp Iii, Llc 10 percent owner 514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
J Daniel Mccranie director C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Edward J Hejlek officer: See Remarks C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538